Abbott Labs appointment
This article was originally published in The Tan Sheet
Executive SummaryRichard Ashley will fill new position of executive VP-corporate development, taking responsibility for "various aspects of corporate strategic planning and business development" and reporting to Abbott CEO Miles White, firm announces Feb. 2. Ashley, who has a law degree from the University of Wisconsin, previously had retired as senior director from management consulting firm McKinsey & Company in 2003 after 31 years of working on corporate strategy, organization, and governance...
You may also be interested in...
A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.
Amid the ongoing spread of the coronavirus outbreak, China turns to novel and repurposed antiviral drugs but also courts traditional medicines to ease public fear over the largely unknown threat.
With Pataday Once Daily Relief (0.2% olopatadine) and Twice Daily (0.1%), Alcon adds allergy treatment to its lineup of OTC drops indicated for dry eye and redness. “Obviously, eye allergy will become a much bigger part of the portfolio for us,” says US vision care GM Sean Clark.